Chlamydia pneumoniae and atherosclerosis

Acta Chirurgica Belgica

Volumn 102, Issue 5, 2002, Pages 317-322

  Hoymans, V Y ^a,b   Bosmans, J M ^a   Ieven, M ^a   Vrints, C J ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Atherosclerosis; Chlamydia pneumonias; Infection

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL ANTIGEN;

ADOLESCENT; ADULT; ANIMAL; ARTERIOSCLEROSIS; BACTERIAL INFECTION; CHILD; CHLAMYDOPHILA PNEUMONIAE; EPIDEMIOLOGY; FEMALE; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MONONUCLEAR CELL; MOUSE; RABBIT; REVIEW; RISK FACTOR;

ADOLESCENT; ADULT; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; ARTERIOSCLEROSIS; CHILD; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MICE; RABBITS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

EID: 0036780359     PISSN: 00015458     EISSN: 25770160     Source Type: Journal    
DOI: 10.1080/00015458.2002.11679323     Document Type: Article

References (39)

1. SAIKKU P., MATTILA K., NIEMINEN M. S., MAKELA PH., HUTTUNEN J K , VALTONEN V. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction Lancet, 1988, 2 : 983-6.
2. BLANCHARD T. J , MABEY D. C. W. Chlamydial infections. In : EMMERSON A. M., HAWKEY P. M., GILLESPIE S. H. (eds ). Principles and practice of clinical bacteriology. John Wiley & sons, 1997 : 723-43.
3. GRAYSTON J. T. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J Infect Dis, 2000, 181 : S402-10.
4. RIDKER P. M., KUNDSIN R. B., STAMPFER M. J., POULIN S., HENNEKENS C.H. Prospective study of Chlamydia pneumoniae IgG scropositivity and risks of future myocardial infarction. Circulation, 1999, 99 : 1161-4.
5. NIETO F. J., FOLSOM A. R., SORLIE P. D., GRAYSTON J. T., WANG S. P., LLOYD E. Chlamydia pneumoniae infection and incident coronary heart disease. Am J Epidemiol, 1999, 150 : 149-56.
6. TAVENDALE R., PARRATT D., PRINGLE S. D., BROOK R. A., TUNSTALL-PEDOE H. Serological markers of Chlamydia pneumoniae infection in men and women and subsequent coronary events. Eur Heart J, 2002, 23 : 301-307.
7. STRACHAND P., CARRINGTON D., MENDALL M. A. et al Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the Caerphilly prospective heart disease study. BMJ, 1999, 318 : 1035-40.
8. RIDKER P. M., HENNEKENS CH., BURING J. E., KUNDSIN R., SHIH J. Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori. Herpes Simplex Virus, and Cytomegalovirus and the risk for cardiovascular disease in women. Ann Intern Med, 1999, 131 : 573-7.
9. DANESH J., WHINCUP P., WALKER M. et al. Chlamydia pneumoniae IgG titres and coronary heart disease : prospective study and meta-analysis. BMJ, 2000, 321 : 208-13.
10. WALD N. J , LAW M. R., MORRIS J. K., ZHOU X., WONG Y., WARD M. E. Chlamydia pneumoniae infection and mortality from ischaemic heart disease : large prospective study. BMJ, 2000, 321 : 204-7.
11. SISCOVICK D. S., SCHWARTZ S. M., COREY L. et al. Chlamydia pneumoniae. Herpes Simplex Virus type 1, and Cytomegalovirus and incident myocardial infarction and coronary heart disease in older adults. Circulation, 2000, 102 : 2335-40.
12. VON HERTZEN L., ISOAHO R., KIVELA S. L., SAIKKU P. Relation of C pneumoniae antibodies to ischaemic heart disease. BMJ, 1999, 319 : 1575-6
13. GLADER C. A., BOMAN J., SAIKKU P. et al. The proatherogenic properties of lipoprotein(a) may be enhanced through the formation of circulating immune complexes containing Chlamydia pneumoniae-specific IgG antibodies Eur Heart J, 2000, 21 : 639-46.
14. SAIKKU P., LEINONEN M., TENKANEN L. et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med, 1992, 116 : 273-278.
15. PEELING R. W., WANG S. P., GRAYSTON J. T. et al. Chlamydia pneumoniae serology : interlaboratory variation in microimmunofluorescence assay results. J Infect Dis, 2000, 181 (Suppl. 3) : S426-9
16. SHOR A., KUO C. C., PATTON D. L. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J. 1992, 82 : 158-61 .
17. KUO C. C., SHOR A., CAMPBELL L. A., FUKUSHI, PATTON D. L., GRAYSTON J. T. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis, 1993, 167 : 841-9.
18. HOYMANS V., BOSMANS J., URSI D. et al. Systemic Inflammation, Chlamydia pneumoniae DNA in circulating leukocytes and coronary atherosclerosis'. Acta Cardiologica- in press..
19. DOWELL S. F., PEELING R. W., BOMAN J. et al. Standardizing Chlamydia pneumoniae assays: Recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin linfect Dis, 2001, 33 : 492-502.
20. APFALTER P., BLASI F., BOMAN J. et al. Multicenter comparison trial of DNA extraction methods and PCR assays for defection of Chlamydia pneumoniae in endarterectomy specimens. J Clin Microbiol, 2001, 39 : 519-24.
21. FONG I. W., CHIU B., VIIRA E. et al. Can an antibiotic (macrolide) prevent Chlamydia pneumoniae - induced atherosclerosis in a rbbit model ? Clin Diagn Lab Immunol, 1999, 6 : 891-4.
22. MUHLESTEIN J. B., ANDERSON J. L., HAMMOND E. H. et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation, 1998, 97 : 633-6.
23. ROTHSTEIN N. M., QUINN T. C., MADICO G., GAYDOS C. A , LOWENSTEIN C. J Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae. J Infect Dis, 2001, 183 : 232-8.
24. MEIER C. R., DERBY L. E., JICK S. S., VASILAKIS C., JICK H. Antibiotics and risk of subsequent first-time acute myocardial infarction. JAMA, 1999, 281 : 427-31.
25. JACKSON L. A., SMITH N. L., HECKBERT S. R., GRAYSTON J. T., SISCOVICK D. S., PSATY B. M. Lack of association between first myocardial infarction and past use of erythromycin, tetracycline, or doxycycline. Emerg Infect Dis, 1999, 5 : 281-4.
26. PILOTE L., GREEN L., JOSEPH L., RICHARD H., EISENBERG M. J. Antibiotics against Chlamydia pneumoniae and prognosis after acute myocardial infarction. Am Heart J, 2002, 143 : 294-300.
27. GUPTA S., LEATHAM E. W., CARRINGTON D., MENDALL M. A., KASKI J. C., CAMM A. J. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation, 1997, 96 : 404-7 .
28. GURFINKEL E., BOZOVICH G , BECK E., TESTA E., LIVELLARA B., MAUTNER B. Treatment with the antibiotic roxithromycin inpatients with acute non-Q-wave coronary syndromes. The final report of the ROXIS study. Eur Heart J, 1999, 20 : 121-7.
29. MUHLESTEIN J. B., ANDERSON J. L., CARLQUIST J. F. et al. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease. Circulation, 2000, 102 : 1755-60.
30. ANDERSON J. L., MUHLESTEIN J. B., CARLQUIST J. et al. Randomized secondary trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection. Circulation, 1999, 99 : 1540-1547.
31. MEIER C. R. Antibiotics in the prevention and treatment of coronary heart disease J Infect Dis, 2000, 181 : S558-62.
32. GAYDOS C. A., SUMMERSGILL J. T., SAHNEY N. N., RAMIREZ J. A., QUINN T. C. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun, 1996, 64 : 1614-20.
33. KALAYOGLU M. V , BYRNE G. I. A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlarnydial lipopolysaccharide. Infect Immun, 1998, 66 : 5067-72.
34. KRULL M., KLUCKEN A. C , WUPPERMANN F. N et al. Signal transduction pathways activated in endothelial cells following infection with Chlamydia pneumoniae. J Immunol, 1999, 162 : 4834-41.
35. FRYER R. H., SCHWOBE E. P., WOODS M. L., RODGERS G. M. Chlamydia species infect human vascular endothelial cells and induce procuagulant activity J Invest Med, 1997, 45 : 168-74.
36. MOLESTINA R. E., MILLER R. D., RAMIREZ, J. A., SUMMERSGILL J. T. Infection of human endothelial cells with Chlamydia pneumoniae stimulates transendothelial migration of neutrophils and monocytes. Infect Immun, 1999, 67 : 1323-30.
37. SUVI-SIRKKU E., TEPPO A. M., LAITINEN K., SAIKKU P., LINNAVUORI K., LEINONEN M. Growth of Chlamydia pneumoniae in cultured human PBMC and induction of a cytokine response. Microbial Pathogenesis, 1996, 21 : 215-21.
38. NETEA M. G., SELZMAN CH , KULLBERG B. J. et al Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells Eur J Immunol, 2000, 30 : 541-9.
39. KOL A, SUKHOVA G. K., LICHTMAN A. H., LIBBY P. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-a and matrix metalloproteinase expression. Circulation, 1998, 98 . 300-7.